Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Li, Banban"" wg kryterium: Autor


Wyświetlanie 1-12 z 12
Tytuł:
The Association between Teacher-Student Relationship and Academic Achievement: The Moderating Effect of Parental Involvement
Autorzy:
Ma, Lihong (ORCID 0000-0002-3603-3301)
Liu, Jian (ORCID 0000-0001-7501-6881)
Li, Banban (ORCID 0000-0003-3142-110X)
Pokaż więcej
Deskryptory:
Teacher Student Relationship
Parent Participation
Adolescents
Correlation
Grade 4
Grade 11
Student Attitudes
Academic Achievement
Age Differences
Foreign Countries
Źródło:
Psychology in the Schools. Feb 2022 59(2):281-296.
Recenzowane naukowo:
Y
Page Count:
16
Czasopismo naukowe
Tytuł:
RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway
Autorzy:
Sun, JikuiAff1, Aff2
Ma, Quanfeng
Li, Banban
Wang, Chen
Mo, Lidong
Zhang, Xuebin
Tang, Fan
Wang, Qiong
Yan, Xiaoling
Yao, Xiuhua
Wu, Qiaoli
Shu, Chang
Xiong, Jinbiao
Fan, Weijia
Wang, JinhuanAff1, Aff2
Pokaż więcej
Źródło:
Cell Death & Disease. 11(10)
Czasopismo naukowe
Tytuł:
RUNX3 inhibits glioma survival and invasion via suppression of the β-catenin/TCF-4 signaling pathway
Autorzy:
Sun, JikuiAff1, Aff2, Aff4, Aff5
Li, Banban
Jia, ZhifanAff4, Aff5, Aff6, Aff7
Zhang, AnlingAff4, Aff5, Aff6, Aff7
Wang, GuangxiuAff4, Aff5, Aff6, Aff7
Chen, ZhijuanAff4, Aff5, Aff6, Aff7
Shang, ZhendeAff1, Aff2
Zhang, Chaocai
Cui, Jian
Yang, WeidongAff4, Aff5, Aff6, Aff7
Pokaż więcej
Źródło:
Journal of Neuro-Oncology. 140(1):15-26
Czasopismo naukowe
Tytuł:
[Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them].
Autorzy:
Shi Y; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Li P; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Li B; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhang F; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Huang S; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Shen S; Department of Tumor Radiotherapy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Li X; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Pokaż więcej
Źródło:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2019 May 20; Vol. 22 (5), pp. 299-305.
Typ publikacji:
Journal Article
MeSH Terms:
Mutation*
Carcinoma, Non-Small-Cell Lung/*drug therapy
Carcinoma, Non-Small-Cell Lung/*genetics
Lung Neoplasms/*drug therapy
Lung Neoplasms/*genetics
Protein Kinase Inhibitors/*pharmacology
Disease-Free Survival ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Exons/genetics ; Female ; Humans ; Male ; Middle Aged ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
[Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung 
Adenocarcinoma].
Autorzy:
Li P; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
Li B; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
Shi Y; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
Zhang F; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
Shen S; Department of Tumor Radiotherapy, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
Li X; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, 
Zhengzhou 450052, China.
Pokaż więcej
Źródło:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2019 Mar 20; Vol. 22 (3), pp. 137-142.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung/*drug therapy
Adenocarcinoma of Lung/*genetics
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Genes, erbB-2/*genetics
Pemetrexed/*therapeutic use
Platinum/*therapeutic use
Adenocarcinoma of Lung/pathology ; Aged ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-12 z 12

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies